About

Yannic Bartsch is head of the junior research group ‘Antiviral Antibody-Omics’ at TWINCORE. His primary research focus is the analysis and understanding of the role of antibody-mediated effects in (infectious) diseases, with the aim of using antibodies therapeutically to attenuate the course of infections.


Dr Bartsch obtained his doctorate at the University of Lübeck, where he examined the protective effect of IgG Fc sialylation in mouse models of autoimmune diseases and a mechanism for adjuvant-dependent alteration of IgG glycosylation after vaccination in mice. As a postdoc at the Ragon Institute of the MGH, MIT and Harvard in Cambridge (USA), he investigated the role of the Fc effector functions of antibodies in the laboratories of Prof. Dr Galit Alter and Prof. Dr Boris Julg in viral infections, such as HIV and SARS-CoV-2. Furthermore, he demonstrated the crucial role of Fc-mediated antibody effector function for protection against respiratory syncytial virus (RSV). His research has led to numerous (first) authorships in renowned (peer-reviewed) journals.
 


Publications

2024Allergy : 10.1111/all.16241

Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination

Buhre J, Pongracz T, Geisen U, Schubert M, Wang W, Nouta J, Obara M, Lehrian S, Rahmöller J, Petry J, Tran F, Schreiber S, Sümbül M, Berner D, Gerdes S, Schirmer J, Longardt A, Hoff P, Kalinke U, Ludwig R, Bartsch Y, Hoyer B, Wuhrer M, Ehlers M

2024Research square : rs.3.rs-4139764

The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine

Kutzler M, Cusimano G, Joyner D, Konopka E, Muir R, Barnette P, Guderian M, Del Moral-Sánchez I, Derking R, Bijl T, Snitselaar J, Rotsides P, Woloszczuk K, Bell M, Canziani G, Chaiken I, Hessell A, Bartsch Y, Sanders R, Haddad E

Posts

Yannic Bartsch in front of the TWINCORE sign

New junior research group started at TWINCORE

Yannic Bartsch has been researching "Antiviral Antibody Omics" since January

Read more
Helmholtz Young Investigator Group Leader Yannic Bartsch in the lab.

Helmholtz Young Investigator Group for Yannic Bartsch

Immunologist receives 1.5 million euros in funding

Read more